Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5824_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface
- •Acknowledgments
- •Contents
- •Contributors
- •1: Ultrasound in Reproductive Medicine: Is It Safe?
- •Introduction
- •A Short Review of Ultrasound Physics
- •Instrument Outputs
- •Ultrasound Bioeffects
- •The Output Indices
- •Ovarian Scanning
- •Ultrasound and the Ovum
- •Embryo/Fetus Susceptibility
- •Safety Aspects of Ultrasound in Ovulation Induction and Early Gestation
- •Summary and Recommendations
- •References
- •Tissue Characteristics
- •2: Principles of 3D Ultrasound
- •Introduction
- •Basic Techniques of 3D US
- •Reconstruction and Visualization of 3D Images and Post-processing
- •Advantages and Shortcomings of 3D US Techniques
- •Applications of 3D Ultrasound in ART
- •Conclusions
- •References
- •Introduction
- •Endometrial Blood Flow
- •Blood Flow of Uterine Vessels
- •Endometrial and Subendometrial Blood Flow by 2D Doppler
- •Endometrial and Subendometrial Blood Flow by 3D Doppler
- •Changes in Endometrial and Subendometrial Blood Flow
- •Prediction of Ovarian Response to Gonadotrophin
- •Ovarian Stromal Blood Flow by 2D Doppler
- •Ovarian Stromal Blood Flow by 3D Doppler
- •Conclusion
- •References
- •4: Legal Aspects of Ultrasound Imaging in Reproductive Medicine
- •Legal Aspects of Ultrasound Imaging in Reproductive Medicine
- •Performance of the Ultrasound Study
- •Personnel Performing Ultrasound Examinations
- •Adequacy of the Ultrasound Study
- •Ultrasound Supervision
- •Image Acquisition and Retention
- •Equipment Maintenance
- •Study Interpretation and Reporting
- •New Horizons in Ultrasound Liability
- •First-Trimester Ultrasound
- •Healthcare Fraud
- •Conclusion
- •References
- •5: The Normal Ovary (Changes in the Menstrual Cycle)
- •Transabdominal Ultrasound
- •Transvaginal Ultrasound
- •Postmenopausal Ovaries
- •Premenarchal Ovaries
- •Reproductive Age Ovaries
- •Color Doppler of the Normal Ovary
- •TVCD in Preovulatory Phase
- •TVCD and the Corpus Luteum
- •Three-Dimensional Ultrasound Visualization of the Normal Ovary
- •Volume of the Ovary
- •Antral Follicle Count (AFC)
- •3D of the Dominant Follicle, Ovulation, and Formation of Corpus Luteum
- •3D Power Doppler of the Preovulatory Follicle and Corpus Luteum
- •References
- •6: Ovarian Reserve and Ovarian Cysts
- •Introduction
- •Antral Follicle Count and Ovarian Reserve
- •Endocrine Markers of Ovarian Reserve
- •3D Ultrasound and Ovarian Volume
- •Evaluation of Ovarian Stroma Flow with 3D Ultrasound
- •Ovarian Cysts and Masses
- •Ultrasound and Polycystic Ovary (PCO)
- •Antral Follicle Count and SonoAVC
- •Conclusions
- •References
- •7: Ultrasound and PCOS
- •The Polycystic Ovarian Morphology
- •Follicle Number and Size
- •Ovarian Volume
- •Stromal Area, Volume, and Echogenicity
- •Ovarian Stromal Blood Flow
- •Uterine Size and Perfusion
- •Ultrasound and Assisted Reproduction Outcome
- •Ultrasound and Prevention of OHSS
- •Future Points
- •References
- •8: The Normal Uterus
- •Uterus
- •Myometrium
- •Endometrium
- •Cervix
- •References
- •Uterus Didelphys
- •Bicornuate Uterus
- •Septate Uterus
- •Arcuate Uterus
- •Müllerian Agenesis
- •Clinical Presentation of Congenital Uterine Anomalies
- •Imaging of Congenital Uterine Anomalies
- •Hysterosalpingography
- •Two-Dimensional Ultrasonography
- •Pelvic Magnetic Resonance Imaging
- •Three-Dimensional Ultrasonography
- •Urinary Tract Imaging
- •9: Congenital Uterine Anomalies
- •Introduction
- •Embryology of the Female Reproductive Tract
- •Overview of the Uterine Anomalies
- •Unicornuate Uterus
- •Reproductive Outcomes with Uterine Anomalies
- •Indications for Surgical Intervention
- •Conclusion
- •References
- •10: Uterine Fibroids
- •Background
- •Fibroids and Fertility
- •Fibroids and IVF
- •Myomas and Obstetrical Outcomes
- •Diagnosis of Uterine Fibroids
- •Ultrasound
- •Saline Infusion Sonohysterography
- •Magnetic Resonance Imaging
- •Management of Uterine Fibroids
- •Observation
- •Surgery
- •Hysteroscopic Myomectomy
- •Abdominal Myomectomy
- •Laparoscopic Myomectomy
- •Uterine Artery Embolization
- •MRgFUS
- •Conclusion
- •References
- •11: Endometrial Polyps
- •Introduction
- •Diagnosis
- •Transvaginal Ultrasonography
- •Sonohysterography
- •Three-Dimensional TVUS and Three- Dimensional SIS
- •Other Imaging Modalities
- •False-Positive, False-Negative, and Artifacts
- •Impact of Polyps on Fertility
- •Polyps and Assisted Reproductive Technology
- •Intrauterine Lesions in Patients with Recurrent Implantation Failure
- •Conclusion
- •References
- •12: Intrauterine Adhesions
- •Introduction
- •Incidence
- •Manifestation
- •Causes
- •Risk Factors
- •Effects
- •Diagnosis
- •The Role of Ultrasound in the Diagnosis
- •Management of IUA
- •Hysteroscopic Surgery
- •Treatment Outcome
- •Role of Ultrasonography in the Treatment
- •Radiographic Methods
- •Prevention of IUA
- •Mechanical Barriers
- •Fluid Barriers
- •Tissue Barriers
- •Recent Advances
- •Conclusion
- •References
- •13: Sonohysterography in Reproductive Medicine
- •Introduction
- •SHG vs. Hysteroscopy
- •Practice Guidelines for SHG
- •Indication and Contraindication
- •SHG Procedure [ 14, 27, 28, 32 ]
- •SHG for Congenital Uterine Anomalies
- •SHG for Acquired Uterine Abnormalities
- •2D vs. 3D SHG
- •Gel Instillation SHG
- •No Pain with SHG
- •Conclusions
- •References
- •14: Evaluation of Tubal Patency (HyCoSy, Doppler)
- •Laparoscopy and Dye Test (Chromopertubation)
- •Hysterosalpingography (HSG)
- •The Technique
- •Three-Dimensional Coded Contrast Imaging (3D CCI) During HyCoSy
- •Blood-Flow and Doppler Imaging
- •Conclusion
- •References
- •15: Hydrosalpinx
- •Introduction
- •Anatomy of the Fallopian Tube
- •Tubal Function
- •Signs and Symptoms
- •Effects on Pregnancy
- •Imaging
- •Hysterosalpingogram (HSG)
- •Ultrasound Appearance
- •Color Doppler Sonography
- •Contrast Medium
- •Three-Dimensional (3-D) Ultrasound
- •Utility of Tubal Surgery
- •Assisted Reproduction
- •Conclusions
- •References
- •16: Virtual Hysterosalpingography: A New Diagnostic Technique for the Study of the Female Reproductive Tract
- •General Concepts
- •Clinical Experience with Virtual Hysterosalpingography in Reproductive Medicine
- •Cervical Pathology in Infertility
- •Pathology of the Endometrial Cavity in Infertility
- •Evaluation of the Fallopian Tubes
- •Conclusions
- •References
- •17: Ultrasound in Male Infertility
- •Introduction
- •Overview of Genitourinary Ultrasonography
- •Scrotal Ultrasonography
- •Paratesticular Structures
- •Epididymis
- •Varicocele
- •Vas Deferens
- •Testicular Ultrasound
- •Cryptorchidism
- •Cysts, Hydrocele, Infectious Processes
- •Testicular Masses
- •Microlithiasis
- •Testicular Torsion/Trauma
- •Transrectal Ultrasonography
- •Prostate
- •Cysts
- •Ejaculatory Duct Obstruction
- •Seminal Vesicles
- •Assisted Reproductive Techniques
- •Conclusion
- •References
- •18: Ultrasound in Follicle Monitoring for Ovulation Induction/IUI
- •Follicular Selection: Morphological and Ultrasound Observations
- •The Role of Doppler in Reproduction
- •Ovulation Induction and Intrauterine Insemination (IUI)
- •Multiple Pregnancies
- •Polycystic Ovarian Syndrome (PCOS)
- •The Classical Picture of PCOS
- •Ultrasound Diagnosis
- •Induction of Ovulation
- •Selection of Patients
- •Technical Tips on How to Scan the Ovaries and Follicular Growth
- •Clomiphene Citrate
- •Antiestrogenic Effects on the Cervix and Endometrium
- •Treatment Schema and Monitoring of Clomiphene Citrate Therapy
- •Gonadotropins
- •Clomiphene Citrate and hMG
- •The Help of Ultrasound: Assessing Complications
- •Final Remarks
- •References
- •19: 2D Ultrasound in Follicle Monitoring for ART
- •Introduction
- •Why Monitor the Follicular Phase?
- •Normal Folliculogenesis
- •Monitoring Follicular Maturation
- •Methods for Monitoring
- •Standard Ultrasound Monitoring Program
- •Follicular Size and Volume
- •Criteria Used for Triggering Ovulation
- •How to Predict Retrieval of Mature Oocytes?
- •Monitoring of Endometrial Proliferation
- •Monitoring with 2D Versus 3D
- •Monitoring with Power Doppler (In Relation to 2D)
- •Conclusion
- •References
- •20: 3D Ultrasound for Follicle Monitoring in ART
- •Introduction
- •Use of 3D Ultrasound of the Female Reproductive System Before and During IVF in Regard to Endometrial Receptivity
- •US Monitoring of Polycystic Ovary Syndrome (PCOS) Patients
- •Ultrasound in Estimation of the Ovarian Reserve
- •Follicle Tracking During Controlled Ovarian Hyperstimulation
- •New Applications of 3D US
- •Optimal Outpatient Monitoring
- •Conclusions
- •References
- •21: Ultrasound-Guided Surgical Procedures
- •Introduction
- •Ultrasound Guidance at Time of Uterine Surgery: Uterine Septum Resection, Myoma Excision, Synechiae Lysis, Intrauterine Foreign Bodies, Hematometra
- •Uterine Septum
- •Submucosal Fibroids
- •Synechiae
- •Intrauterine Foreign Bodies
- •Hematometra
- •Limitations of the Technique
- •Summary
- •Ovarian Cyst and Hydrosalpinx Aspiration
- •Ovarian Cyst Aspiration
- •Hydrosalpinx Aspiration
- •Oocyte Retrieval
- •Embryo Transfer
- •Intrauterine Device Placement and Removal
- •Conclusion
- •References
- •22: Ultrasound Role in Embryo Transfers
- •Introduction
- •Transvaginal Versus Transabdominal Ultrasound for ET
- •Training in Embryo Transfer
- •Conclusion
- •References
- •23: Ultrasound and Ovarian Hyperstimulation Syndrome
- •Ultrasound in the Prediction of Ovarian Hyperstimulation Syndrome
- •Ultrasound in the Diagnosis of Ovarian Hyperstimulation Syndrome
- •Ultrasound in the Management and Treatment of Ovarian Hyperstimulation Syndrome
- •References
- •24: Pregnancy of Unknown Viability
- •Introduction
- •Early Pregnancy Complications: Vaginal Bleeding and Pelvic Pain
- •History and Physical Exam
- •β-hCG
- •Progesterone
- •Ultrasound
- •Ultrasound Characteristics of Normal Intrauterine Pregnancy
- •Ultrasound Characteristics of Abnormal Pregnancy
- •Pregnancy of Unknown Location (PUL)
- •Ultrasound Characteristics of Early Pregnancy Failure and Intrauterine Pregnancy of Unknown Viability
- •Conclusion
- •References
- •25: Ultrasound Evaluation of Ectopic Pregnancy
- •Cervical Pregnancy
- •Ovarian Pregnancy
- •Abdominal Pregnancy
- •Cesarean Scar Ectopic Pregnancy
- •Interstitial Ectopic Pregnancy
- •Ectopic After Hysterectomy
- •Summary
- •References
- •26: Focused Ultrasound for Treatment of Fibroids
- •Introduction
- •How Does It Work?
- •Patient Selection
- •Impact on Future Fertility
- •Other Conditions That Can Be Treated
- •Adenomyosis
- •Patient Preparation
- •Treatment
- •Outcomes
- •Cost
- •Conclusion
- •References
- •Index

24
M. Murtinger et al.
SonoAVC (GE Medical Systems, Kretztechnik,
Zipf, Austria) are user-friendly systems, which
can accurately determine follicle number and
size.
Currently, 3D ultrasound is widely used for
monitoring the course of pregnancy. It allows
imaging the developing fetus. With the quality
3D images that this type of ultrasound produces,
physicians can clearly assess the health condition
of the infant or any anomalies, such as cleft palate, spina bifi da, anencephaly, and cardiac
defects. It provides quantifi able nuchal scan measurements to facilitate the calculation of the risk
of chromosomal defects such as Down syndrome
[ 41 ]. In addition, it facilitates gender determina-
tion [ 42 ]. 3D ultrasound is not only applied in
fetal and gynecologic imaging, but also in other
medical procedures such as surgeries or biopsies
[ 43 , 44 ]. Moreover, 3D US is being adopted by
other medical fi elds such as cardiology and neurology [ 45 – 47 ]. Furthermore, it is used in several
other fi elds and its application is at the forefront
of current medical technology.
Conclusions
Three-dimensional US opens up new clinical
applications and facilitates many of the proce-
dures originally performed with 2D US. The
advantages of this relatively new, noninvasive
technique have been reported in many special-
ties. Only a few limitations must be kept in
mind, such as the more complex interface that
requires a steeper learning curve. However,
the advantages it provides not only in the fi eld
of ART is striking, and instruments as well as
supporting software programs are becoming
more and more user friendly. Operation of the
systems has become facilitated and the pro-
cessing time has been signifi cantly shortened.
The progress in software regarding imaging
and image remodeling as well as the variety of
imaging modes facilitates optimal diagnosis
and therapy. Three-dimensional sonography
has been adopted by several medical fi elds
such as prenatal care, and it is becoming
increasingly acceptable as a diagnostic tool.
There is no doubt that this innovative method
will also be fully established in ART.
References
1. Mahadevan M, Chalder K, Wiseman D, Leader A,
Taylor PJ. Evidence for an absence of deleterious
effects of ultrasound on human oocytes. J In Vitro Fert
Embryo Transf. 1987;4:277–80.
2. Hershkovitz R, Sheiner E, Mazor M. Ultrasound in
obstetrics: a review of safety. Eur J Obstet Gynecol
Reprod Biol. 2002;101:15–8. Review.
3. Brinkley JF, Muramatsu SK, McCallum WD, Popp
RL. In vitro evaluation of an ultrasonic threedimensional imaging and volume system. Ultrason
Imaging. 1982;4:126–39.
4. Rinck PA, Petersen SB. Muller RN [NMR-whole
body tomography: a new imaging method]. Radiologe.
1983;23:341–6.
5. Vannier MW, Marsh JL, Warren JO. Threedimensional CT reconstruction images for craniofacial surgical planning and evaluation. Radiology.
1984;150:179–84.
6. Lees W. Ultrasound imaging in three and four dimensions. Semin Ultrasound CT MR. 2001;22:85–105.
Review.
7. Baba K, Satoh K. Development of a system for
ultrasonic fetal three-dimensional reconstruction.
Acta Obstet Gynaecol Jpn. 1986;38:1385.
8. Baba K, Satch K, Sakamoto S, Oka T, Shiego I.
Development of an ultrasonic system for threedimensional reconstruction of the fetus. J Perinat
Med. 1989;17:19–24.
9. Von Ramm OT, Smith SW. Three-dimensional imaging system.1987. United States Patent 4694434.
http://www.freepatentsonline.com/4694434.html .
Last accessed on 23 May 2013.
10. OBGYN.NET. Kretz museum tour – the history of
ultrasound.
display/article/1760982/1953224
23 May 2013.
11. Brandl H, Gritzky A, Haizinger M. 3D ultrasound:
a dedicated system. Eur Radiol. 1999;9:331–3. Review.
12. Alcazar JL. The use of three-dimensional ultrasound
in gynecological patients. Donald Sch J Ultrasound
Obstet Gynecol. 2008;2:10–6.
13. Miller DL. Safety assurance in obstetrical ultrasound.
Semin Ultrasound CT MR. 2008;29:156–64. Review.
14. Merz E. 3D ultrasound in prenatal diagnosis. Curr
Obstet Gynecol. 1999;9:93–100.
15. Zhang H, Banovac F, White A, Cleary K. Freehand
3D ultrasound calibration using an electromagnetically tracked needle. Available from:
proceedings.spiedigitallibrary.org/proceeding.
aspx?articleid=1276235
2013.
16. Fenster A, Downey DB, Cardinal HN. Threedimensional ultrasound imaging. Phys Med Biol.
2001;46:R67–99. Review.
17. Dietz HP, Shek KL. Tomographic ultrasound imaging
of the pelvic fl oor: which levels matter most?
Ultrasound Obstet Gynecol. 2009;33:698–703.
http://hcp.obgyn.net/conference-insider/
. Last accessed on
http://
. Last Accessed on 23 May

2 Principles of 3D Ultrasound
25
18. Ruano R. Recent advances in sonographic imaging
of fetal thoracic structures. Expert Rev Med Devices.
2005;2:217–22. Review.
19. Jouannic JM, Rosenblatt J, Demaria F, Jacobs R,
Aubry MC, Benifl a JL. Contribution of threedimensional volume contrast imaging to the sonographic assessment of the fetal uterus. Ultrasound
Obstet Gynecol. 2005;26:567–70.
20. Benacerraf BR. Inversion mode display of 3D sonography: applications in obstetric and gynecologic imaging. AJR Am J Roentgenol. 2006;187:965–71. Review.
21. Weber G, Merz E, Bahlmann F, Macchiella D.
Ultrasound assessment of ovarian tumors–comparison between transvaginal 3D technique and conventional 2-dimensional vaginal ultrasonography.
Ultraschall Med. 1997;18:26–30.
22. Campbell S. The potential diagnostic capabilities of
three-dimensional surface rendering. Ultrasound
Obstet Gynecol. 1999;14:148.
23. Turan S, Turan O, Baschat AA. Three- and fourdimensional fetal echocardiography. Fetal Diagn
Ther. 2009;25:361–72. Review.
24. Adriaanse BM, Tromp CH, Simpson JM,
Van Mieghem T, Kist WJ, Kuik DJ, Oepkes D,
Van Vugt JM, Haak MC. Interobserver agreement in
detailed prenatal diagnosis of congenital heart disease
by telemedicine using four-dimensional ultrasound
with spatiotemporal image correlation. Ultrasound
Obstet Gynecol. 2012;39:203–9.
25. Hongmei W, Ying Z, Ailu C, Wei S. Novel application
of four-dimensional sonography with B-fl ow imaging
and spatiotemporal image correlation in the assessment of fetal congenital heart defects. Echocardiography. 2012;29:614–9.
26. Yeo L, Romero R, Jodicke C, Oggè G, Lee W,
Kusanovic JP, Vaisbuch E, Hassan S. Four-chamber
view and ‘swing technique’ (FAST) echo: a novel and
simple algorithm to visualize standard fetal echocardiographic planes. Ultrasound Obstet Gynecol. 2011;
37:423–31.
27. Merz E, Miric-Tesanic D, Welter C. Value of the electronic scalpel (cut mode) in the evaluation of the fetal
face. Ultrasound Obstet Gynecol. 2000;16:564–8.
28. Powers J, Kremkau F. Medical ultrasound systems.
Interface Focus. 2011;1:477–89.
29. Udupa JK. Three-dimensional visualization and
analysis methodologies: a current perspective. Radiographics. 1999;19:783–806. Review.
30. Nelson TR, Pretorius DH, Lev-Toaff A, Bega G,
Budorick NE, Hollenbach KA, Needleman L. Feasibility
of performing a virtual patient examination using threedimensional ultrasonographic data acquired at remote
locations. J Ultrasound Med. 2001;20:941–52.
31. Merz E, Abramowicz JS. 3D/4D ultrasound in prenatal diagnosis: is it time for routine use? Clin Obstet
Gynecol. 2012;55:336–51. Review.
32. Rizzo G, Pietrolucci M, Aiello E, Mammarella S,
Bosi C, Arduini D. The role of three-dimensional ultrasound in the diagnosis of fetal congenital anomalies:
a review. Minerva Ginecol. 2011;63:401–10. Review.
33. Bulletti C, DE Ziegler D, Levi Setti P, Cicinelli E,
Polli V, Stefanetti M. Myomas, pregnancy outcome,
and in vitro fertilization. Ann N Y Acad Sci. 2004;
1034:84–92.
34. Raga F, Bonilla-Musoles F, Blanes J, Osborne NG.
Congenital Müllerian anomalies: diagnostic accuracy
of three-dimensional ultrasound. Fertil Steril. 1996;
65:523–8.
35. Wu MH, Hsu CC, Huang KE. Detection of congenital
müllerian duct anomalies using three-dimensional
ultrasound. J Clin Ultrasound. 1997;25:487–92.
36. Ghi T, Casadio P, Kuleva M, Perrone AM, Savelli L,
Giunchi S, et al. Accuracy of three-dimensional
ultrasound in diagnosis and classifi cation of congenital uterine anomalies. Fertil Steril. 2009;92:808–13.
37. Rosendahl M, Ernst E, Rasmussen PE, Andersen CY.
True ovarian volume is underestimated by twodimensional transvaginal ultrasound measurement.
Fertil Steril. 2010;93:995–8.
38. Vanderzwalmen P, Zech NH, Ectors F, Stecher A,
Lejeune B, Vanderzwalmen S, Wirleitner B. Blastocyst
transfer after aseptic vitrifi cation of zygotes: an
approach to overcome an impaired uterine environment. Reprod Biomed Online. 2012;25:591–9.
39. Sladkevicius P, Ojha K, Campbell S, Nargund G.
Three-dimensional power Doppler imaging in the
assessment of Fallopian tube patency. Ultrasound
Obstet Gynecol. 2000;16:644–7.
40. Deb S, Campbell BK, Clewes JS, Raine-Fenning NJ.
Quantitative analysis of antral follicle number and
size: a comparison of two-dimensional and automated
three-dimensional ultrasound techniques. Ultrasound
Obstet Gynecol. 2010;35:354–60.
41. Shaw SW, Hsieh TT, Hsu JJ, Lee CL, Cheng PJ.
Measurement of nuchal volume in the fi rst trimester
down screening using three-dimensional ultrasound.
Prenat Diagn. 2009;29:69–73.
42. Youssef A, Arcangeli T, Radico D, Contro E,
Guasina F, Bellussi F, Maroni E, Morselli-Labate AM,
Farina A, Pilu G, Pelusi G, Ghi T. Accuracy of
fetal gender determination in the fi rst trimester using
three- dimensional ultrasound. Ultrasound Obstet
Gynecol. 2011;37:557–61.
43. Jang M, Kim SM, Lyou CY, Choi BS, Choi SI,
Kim JH. Differentiating benign from malignant thyroid nodules: comparison of 2- and 3- dimensional
sonography. J Ultrasound Med. 2012;31:197–204.
44. Smeenge M, de la Rosette JJ, Wijkstra H. Current
status of transrectal ultrasound techniques in prostate
cancer. Curr Opin Urol. 2012;22:297–302. Review.
45. Downey DB, Fenster A. Vascular imaging with a
three-dimensional power Doppler system. AJR Am
J Roentgenol. 1995;165:665–8.
46. Houck RC, Cooke JE, Gill EA. Live 3D echocardiography: a replacement for traditional 2D echocardiography?
AJR Am J Roentgenol. 2006;187:1092–106. Review.
47. Pooh RK, Kurjak A. 3D and 4D sonography and magnetic resonance in the assessment of normal and
abnormal CNS development: alternative or complementary. J Perinat Med. 2011;39:3–13.

Two-Dimensional
and Three- Dimensional Doppler
in Reproductive Medicine
Ernest Hung Yu Ng
3
Introduction
In vitro fertilisation (IVF) is an effective treatment
for various causes of infertility and typically
involves multiple follicular development, oocyte
retrieval and embryo transfer after fertilisation.
Multiple embryos are still being replaced in order
to compensate for their low implantation potential, which have remained steady at 20–30 % for
a long time. Development of multiple follicles in
response to gonadotrophin stimulation is considered as the key factor leading to successful outcome. Successful implantation is dependent on
interaction between a good quality embryo and a
receptive endometrium.
Ultrasound is essential during the IVF treatment for monitoring the ovarian response to
gonadotrophin and guiding the transvaginal
aspiration of oocytes and transfer of embryos to
the uterine cavity. Angiogenesis plays a critical
role in various female reproductive processes
such as development of a dominant follicle, formation of a corpus luteum, growth of endometrium and implantation [
covers the use of two dimensional (2D) and
three dimensional (3D), in particular the role
of endometrial and subendometrial blood
fl ow determined in predicting the IVF success
E. H. Y. Ng , MD, FRCOG (UK)
Department of Obstetrics and Gynaecology ,
The University of Hong Kong, Queen Mary Hospital ,
Pokfulam , Hong Kong , Hong Kong
e-mail: nghye@hku.hk
1 , 2 ]. This chapter
and the role of ovarian stromal blood fl ow
determined in predicting ovarian response to
gonadotrophin stimulation.
Endometrial Blood Flow
Ultrasound examination of the endometrium
serves a non-invasive evaluation of the endometrium during IVF treatment [ 3 ]. Parameters such
as endometrial thickness, endometrial pattern,
endometrial volume and Doppler study of uterine
arteries and the endometrium are most commonly
used to evaluate the endometrial receptivity.
Endometrial thickness and pattern have low positive predictive value and specifi city for the IVF
outcome [ 4 , 5 ], whereas endometrial volume
measured by 3D ultrasound is not predictive of
pregnancy [ 6 – 9 ].
Assessment of endometrial blood fl ow gives a
physiological dimension to the anatomical ultrasound parameters. A good blood fl ow towards the
endometrium is usually considered as an essential
requirement for successful implantation. Jinno
et al. [ 10 ] measured endometrial tissue blood fl ow
in infertile patients by the intrauterine laser Doppler
technique between days 4 and 6 of the luteal phase
of a spontaneous cycle preceding IVF. The IVF
pregnancy rate was signifi cantly higher in women
with endometrial tissue blood fl ow of at least
29 mL/min/100 g of tissue than in women with
lower values (42 % vs. 15 %, respectively, P < 0.05).
Endometrial blood fl ow comes from the radial
artery, which divides after passing through the
L.A. Stadtmauer, I. Tur-Kaspa (eds.), Ultrasound Imaging in Reproductive Medicine,
DOI 10.1007/978-1-4614-9182-8_3, © Springer Science+Business Media New York 2014
27

28
E.H.Y. Ng
myometrial-endometrial junction to form the
basal arteries that supply the basal portion of the
endometrium and the spiral arteries that continue
up towards the endometrium. Endometrial blood
fl ow can be determined by colour and power
Doppler ultrasound. Power Doppler imaging is
more sensitive than colour Doppler imaging at
detecting low-velocity fl ow and hence improves
the visualisation of small vessels [ 11 ]. In combi-
nation with 3D ultrasound, power Doppler can
objectively examine both endometrial and subendometrial blood fl ow.
a
Blood Flow of Uterine Vessels
Doppler study of uterine vessels refl ecting downstream impedance to fl ow is assumed to refl ect the
endometrial blood fl ow. It is usually expressed as
the pulsatility index (PI) and the resistance index
(RI) (Fig. 3.1 ). PI is calculated as the peak sys-
tolic velocity (PSV) minus end-diastolic velocity
divided by the mean, whereas RI is the ratio of
PSV minus end-diastolic velocity divided by PSV.
Flow velocity waveforms are obtained from
the ascending main branch of the uterine artery
Fig. 3.1 Right ( a ) and left
( b ) uterine blood fl ow
measured by 2D Doppler
ultrasound
b

3 Two-Dimensional and Three-Dimensional Doppler in Reproductive Medicine
29
on the right and left side of the cervix in a
longitudinal plane before it enters the uterus.
The ‘gate’ of the Doppler is positioned when the
vessel with good colour signals is identifi ed on
the screen. The PI and RI of the uterine arteries
were calculated electronically when three similar, consecutive waveforms of good quality were
obtained.
Good uterine blood fl ow as shown by low PI
or RI is correlated with successful IVF outcomes [ 12 , 13 ]. Steer et al. [ 12 ] classifi ed PI
measured on the day of ET as low, medium and
high in the ranges of 0–1.99, 2.00–2.99 and
≥3.00, respectively, and reported a 35 % implantation failure when PI was >3.0. Using a PI
upper limit of 3.0 [ 12 ] or 3.3 [ 13 ], the uterine
Doppler fl ow indices have a high negative predictive value and sensitivity (in the ranges of
88–100 % and 96–100 %, respectively) and a
relatively higher range of positive predictive
value and specifi city (44–56 % and 13–35 %,
respectively) when compared with endometrial
thickness and pattern [ 5 ].
Uterine artery Doppler study may not refl ect
the actual blood fl ow to the endometrium as the
major compartment of the uterus is the myometrium and there is collateral circulation between
uterine and ovarian vessels. I have shown 2D
Doppler study of uterine vessels is a poor refl ection of subendometrial blood fl ow by 3D power
Doppler in both stimulated and natural cycles as
endometrial and subendometrial 3D Doppler fl ow
indices were similar among patients with averaged uterine PI <2.0, 2.0–2.99 and ≥3.0. [ 14 ].
Endometrial and Subendometrial Blood Flow by 2D Doppler
Endometrial and subendometrial blood fl ow
examined by colour (Table 3.1 ) and power
Doppler (Table 3.2 ) was correlated with implan-
tation or pregnancy rates during IVF treatment.
2D Doppler fl ow indices of spiral arteries such
as PI and PSV are not predictive of pregnancy [ 8 ,
19 , 22 ], although Battaglia et al. [ 16 ] and
Kupesic et al. [ 23 ] found signifi cantly lower spi-
ral artery PI in pregnant cycles than nonpregnant
cycles.
Yang et al. [ 18 ] used a computer software to
measure the area and intensity of colour signals
present in the endometrium in a longitudinal axis,
i.e. intraendometrial power Doppler area (EDPA).
Signifi cantly higher EDPA was found in pregnant
cycles than nonpregnant cycles (8.8 mm 2 vs.
5.8 mm 2 respectively). Patients with EDPA
<5 mm 2 had signifi cantly lower pregnancy rate
(23.5 % vs. 47.5 %; P = 0.021) and implantation
rate (8.1 % vs. 20.2 %; P = 0.003) than those
with ≥5 mm 2 . Contart et al. [ 20 ] graded endome-
trial blood fl ow by the visualisation of power
Doppler in the quadrants in the fundal region of
Table 3.1 Summary of studies of endometrial blood fl ow by 2D colour Doppler
Study
Popovic-Todorovic
15 ]
et al. [
Battaglia et al. [
Chien et al. [
USS ultrasound, PI pulsatility index, PSV peak systolic velocity, OR oocyte retrieval, ET embryo transfer
IVF cycles USS parameters USS day
96 cycles using a
long protocol
16 ] 60 cycles Uterine and spiral PI OR Uterine and spiral PI lower in
17 ] 623 cycles using
ultrashort and
ultralong
protocols
Spiral PI and PSV hCG No difference in subendometrial PI
Presence of endometrial
and subendometrial fl ow
Presence of endometrial
blood fl ow
Uterine and spiral PI and
RI
Presence of endometrial
and subendometrial
(<10 mm) blood fl ow
ET Signifi cantly lower implantation and
Results
and PSV between pregnant and
nonpregnant cycles
Absent subendometrial fl ow
associated with no pregnancy
pregnant than nonpregnant cycles
Absent subendometrial fl ow
associated with no pregnancy
pregnancy rates in patients without
endometrial/subendometrial fl ow
Presence of subendometrial fl ow 5.9
times to become pregnant than those
with absent fl ow

30
Table 3.2 Summary of studies of endometrial blood fl ow by 2D power Doppler
Study
Yang et al. [
Yuval et al. [
Contart et al. [
Schild et al. [
Maugey-Laulon
21 ]
et al. [
USS ultrasound, PI pulsatility index, PSV peak systolic velocity, OR oocyte retrieval, ET embryo transfer
IVF cycles USS parameter USS day
18 ] 95 cycles using long
and short protocols
Endometrium
≥10 mm
19 ] 156 cycles using
a long protocol
20 ] 185 cycles using
a long protocol
8 ] 135 cycles using
a long protocol;
fi rst cycle only
144 cycles using
a long protocol
Intraendometrial power
Doppler area (EDPA)
2
; ≥5 mm 2
<5 mm
PI and RI OR and ET No difference in any USS
Fundal region along
transverse plan; grades I,
II, III and IV according to
visualisation of power
Doppler in the quadrants
PI and PSV of vessels in
endometrium and
subendometrial area
(<5 mm)
Presence of endometrial
and subendometrial blood
fl ow
Results
OR Higher EDPA in pregnant
cycles
Lower implantation and
pregnancy rates when EDPA
2
<5 mm
parameters between pregnant
and nonpregnant cycles
hCG Implantation and pregnancy
rates similar in all grades of
endometrial vascularity
OR No difference in spiral artery
PI and PSV between pregnant
and nonpregnant cycles
Non-detectable spiral blood
fl ow was not associated with a
lower implantation rate
ET Absent endometrial and
subendometrial fl ow associated
with a lower pregnancy rate
E.H.Y. Ng
the transverse plane but could not demonstrate
any predictive value of such grading system.
Presence of endometrial and subendometrial
blood fl ow can be identifi ed easily in 2D Doppler
ultrasound. Absent endometrial and subendometrial blood fl ow has been shown to be associated
with no pregnancy [ 16 , 22 ] or a signifi cantly
lower pregnancy rate [ 17 , 21 ].
Endometrial and Subendometrial Blood Flow by 3D Doppler
3D power Doppler ultrasound with the aid of the
VOCAL® (Virtual Organ Computer-Aided
Analysis) imaging program for the 3D power
Doppler histogram can be used to measure the
endometrial volume and indices of blood fl ow
within the endometrium (Fig. 3.2 ). Vascularisation
index (VI), which measures the ratio of the number of colour voxels to the number of all the
voxels, is thought to represent the presence of
blood vessels (vascularity) in the endometrium,
and this was expressed as a percentage (%) of the
endometrial volume. Flow index (FI), the mean
power Doppler signal intensity inside the endometrium, is thought to express the average intensity
of fl ow. Vascularisation fl ow index (VFI) is a combination of vascularity and fl ow intensity [ 24 ].
The subendometrium can be examined
through the application of ‘shell imaging’ which
allows the user to generate a variable contour that
parallels the originally defi ned surface contour.
The VI, FI and VFI of the subendometrial region
are obtained accordingly (Fig. 3.3 ). The intra-
observer reliability and interobserver reliability
of endometrial and subendometrial blood fl ow by
3D power Doppler have been confi rmed to be
high with all measurements obtaining an intraclass correlation of above 0.9 [ 25 , 26 ].
Studies addressing the role of endometrial
and subendometrial blood fl ow measured by
3D Doppler in IVF treatment are summarised
in Table 3.3 . Schild et al. [ 27 ] measured
the subendometrial blood fl ow after pituitary
downregulation but prior to ovarian stimulation

3 Two-Dimensional and Three-Dimensional Doppler in Reproductive Medicine
a
31
b
Fig. 3.2 Endometrial volume ( a ) and blood fl ow ( b ) measured by 3D Doppler ultrasound

32
E.H.Y. Ng
a
b
Fig. 3.3 Subendometrial volume ( a ) and blood fl ow ( b ) measured by 3D Doppler ultrasound

3 Two-Dimensional and Three-Dimensional Doppler in Reproductive Medicine
33
(continued)
Results
pregnant than nonpregnant cycles
Subendometrial FI is the strongest predictive
factor for IVF in logistic regression analysis
(endometrium <5 mm, no ovarian
cyst of >2.5 cm, serum oestradiol
<60 pg/mL)
Serum FSH < 10 IU/L
No fi broid, ovarian cysts and ovarian
endometriosis
Inclusion criteria hCG Subendometrial VFI higher in pregnant cycles
Age <38 years
Normal uterine cavity
Serum FSH <15 IU/L
between pregnant and nonpregnant cycles
Polycystic ovary syndrome
≥2 good quality embryos
No difference in endometrial and
subendometrial VI between pregnant and
OR
Endometrium <6 mm
Gynaecological surgery
nonpregnant cycles on both days
Endometriosis
Single ovary
Previous operation on uterus or
cycles
Inclusion criteria OR Endometrial VI and VFI lower in pregnant
salpingectomy
subendometrial 3D Doppler fl ow indices
between pregnant and nonpregnant cycles
Normal uterine cavity
Table 3.3 Summary of studies of endometrial and subendometrial blood fl ow by 3D power Doppler ultrasound
IVF cycles Inclusion/exclusion criteria USS day
27 ] 75 cycles using a long protocol Inclusion criteria Before stimulation Subendometrial VI, FI and VFI lower in
Study
Schild et al. [
ET 2 days after TUGOR Downregulation confi rmed
Blastocyst transfer 5 days after
TUGOR
23 ] 89 cycles using a long protocol Inclusion criteria ET (hCG +7) Higher subendometrial FI in pregnant cycles
Kupesic et al. [
ovarian stimulation and ET not given)
28 ] 54 cycles; fi rst cycle only (details of
Wu et al. [
ET 2 days after TUGOR Uterine fi broids
29 ] 42 cycles using a long protocol Exclusion criteria OR No difference in subendometrial VI, FI and VFI
Dorn et al. [
30 ] 35 cycles using a long protocol Exclusion criteria After stimulation and
Järvelä et al. [
cycle only
31 ] 451 cycles using a long protocol; fi rst
Ng et al. [
ET 2 days after TUGOR Normal uterine cavity on scanning
Frozen-thawed embryo transfer
cycles
32 ] 193 cycles Inclusion criteria LH + 1 No difference in endometrial and
Ng et al. [

34
Results
in pregnant cycles
E.H.Y. Ng
subendometrial 3D Doppler fl ow indices on the
2 days and changes in these indices between
pregnant and nonpregnant cycles
First cycle
Normal uterine cavity
Serum FSH <10 IU/L
Regular cycles
IVF cycles Inclusion/exclusion criteria USS day
33 ] 80 cycles using a long protocol Inclusion criteria hCG Higher endometrial VI, FI and VFI
Table 3.3 (continued)
Study
Mercè et al. [
Non-smokers
Normal uterine cavity
ET 2 days after OR First cycle
34 ] 293 cycles using a long protocol Inclusion criteria OR and ET No difference in endometrial and
Ng et al. [
USS ultrasound, VI vascularisation index, FI fl ow index, VFI vascularisation fl ow index, OR oocyte retrieval, ET embryo transfer
Соседние файлы в папке Библиотека им академика М.И. Перельмана
